# Encompass Health (EHC) — Analyst Forecast

EHC · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/ehc/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 15 | 0 | 0 | 15 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $140.00 | $147.25 | $155.00 | 4 |

Last price $127.77 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 10, 2026 | TD Cowen | Maintained | Buy | $140.00 |
| Aug 7, 2026 | Truist Securities | Maintained | Buy | $150.00 |
| Aug 7, 2026 | UBS | Maintained | Buy | $155.00 |
| Aug 6, 2026 | Barclays | Maintained | Overweight | $144.00 |
| May 28, 2026 | TD Cowen | Initiated Coverage | Buy | $125.00 |
| May 5, 2026 | Barclays | Maintained | Overweight | $140.00 |
| Feb 6, 2026 | Barclays | Maintained | Overweight | $153.00 |
| Oct 30, 2025 | Barclays | Maintained | Overweight | $150.00 |
| Oct 2, 2025 | UBS | Maintained | Buy | $150.00 |
| Sep 16, 2025 | Keybanc | Maintained | Overweight | $140.00 |
| Sep 10, 2025 | B of A Securities | Maintained | Buy | $160.00 |
| Aug 14, 2025 | Truist Securities | Maintained | Buy | $140.00 |
| Aug 6, 2025 | UBS | Maintained | Buy | $140.00 |
| Jun 5, 2025 | Stephens & Co. | Maintained | Overweight | $135.00 |
| May 27, 2025 | Keybanc | Maintained | Overweight | $135.00 |
| Apr 28, 2025 | Truist Securities | Maintained | Buy | $135.00 |
| Apr 28, 2025 | RBC Capital | Maintained | Outperform | $125.00 |
| Apr 28, 2025 | UBS | Maintained | Buy | $130.00 |
| Apr 25, 2025 | Barclays | Maintained | Overweight | $129.00 |
| Apr 25, 2025 | Keybanc | Maintained | Overweight | $122.00 |

## Frequently Asked Questions

### What is the price target for EHC stock?

The average 12-month analyst price target for Encompass Health (EHC) is $147.25, with a high estimate of $155.00 and a low of $140.00, across 4 analysts.

### Is EHC a buy, sell, or hold?

Analysts covering Encompass Health currently average a Buy rating: 15 buy, 0 hold and 0 sell, from 15 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for EHC?

The average price target of $147.25 implies 15.25% upside from the last price of $127.77.

### What is the latest analyst rating on EHC?

On Aug 10, 2026, TD Cowen maintained Encompass Health at Buy with a price target of $140.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).